Ascendia CEO Presents on Gene Therapy Drug Delivery Technologies at SAPA Event

Jun 20, 2022, 12:00:00 AM

How Various Clinical Study Stages Influences Oral Formulation Approach

Apr 4, 2022, 12:00:00 AM

Ascendia to Attend DCAT Week

Mar 11, 2022, 12:00:00 AM

Developing an Effective Lipid Nanoparticle Formulation Process for Small Molecule and Biologicals Delivery

Feb 21, 2022, 12:00:00 AM

Amorphous Nanoparticles for Drug Delivery of Poorly Water-Soluble Compounds

Jan 18, 2022, 12:00:00 AM

Ascendia Pharmaceuticals Participates in Virtual Nasdaq Opening Bell Ceremony Celebrating J.P. Morgan Healthcare Conference

Jan 14, 2022, 12:00:00 AM

Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again

Oct 12, 2021, 12:00:00 AM

Ascendia to Highlight CDMO Services at AAPS PharmSci360

Oct 7, 2021, 12:00:00 AM

Development and Scale Up Considerations for Nanosuspension Dosage Forms

Sep 13, 2021, 12:00:00 AM

How to Successfully Utilize ASDs for Drug Delivery of Insoluble Drugs

Aug 20, 2021, 12:00:00 AM

Top Considerations When Developing Formulations for Injectable Solutions

Aug 11, 2021, 12:00:00 AM

Considerations in Development and Manufacturing of Complex Injectables for Early Phase Studies

Aug 3, 2021, 12:00:00 AM